Irvine's Cardiac Science Inc. has completed private placements totaling $38 million.
Lead contributors for the deal were Houston's AIM Investment Funds and New York-based Special Situations Private Equity Fund.
Medical device maker Cardiac Science manufactures the Powerheart External Cardioverter Defibrillator, which constant...
Lead contributors for the deal were Houston's AIM Investment Funds and New York-based Special Situations Private Equity Fund.
Medical device maker Cardiac Science manufactures the Powerheart External Cardioverter Defibrillator, which constant...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In